Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

A controlled trial of idebenone in Huntington's disease.

Ranen NG, Peyser CE, Coyle JT, Bylsma FW, Sherr M, Day L, Folstein MF, Brandt J, Ross CA, Folstein SE.

Mov Disord. 1996 Sep;11(5):549-54.

PMID:
8866496
3.

Riluzole in Huntington's disease: a 3-year, randomized controlled study.

Landwehrmeyer GB, Dubois B, de Yébenes JG, Kremer B, Gaus W, Kraus PH, Przuntek H, Dib M, Doble A, Fischer W, Ludolph AC; European Huntington's Disease Initiative Study Group.

Ann Neurol. 2007 Sep;62(3):262-72.

PMID:
17702031
4.

Assessment of adaptive functioning in Huntington's disease.

Bylsma FW, Rothlind J, Hall MR, Folstein SE, Brandt J.

Mov Disord. 1993 Apr;8(2):183-90.

PMID:
8474487
5.

Assessment of coenzyme Q10 tolerability in Huntington's disease.

Feigin A, Kieburtz K, Como P, Hickey C, Claude K, Abwender D, Zimmerman C, Steinberg K, Shoulson I.

Mov Disord. 1996 May;11(3):321-3.

PMID:
8723151
6.
7.

A randomised, placebo-controlled, double blind study of treatment of Huntington's disease with unsaturated fatty acids.

Vaddadi KS, Soosai E, Chiu E, Dingjan P.

Neuroreport. 2002 Jan 21;13(1):29-33. Erratum in: Neuroreport 2002 Feb;13(2):inside back cover.

PMID:
11924889
8.

A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease.

Huntington Study Group.

Neurology. 2001 Aug 14;57(3):397-404.

PMID:
11502903
9.
10.

Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study.

van Vugt JP, Siesling S, Vergeer M, van der Velde EA, Roos RA.

J Neurol Neurosurg Psychiatry. 1997 Jul;63(1):35-9.

11.

A controlled trial of remacemide hydrochloride in Huntington's disease.

Kieburtz K, Feigin A, McDermott M, Como P, Abwender D, Zimmerman C, Hickey C, Orme C, Claude K, Sotack J, Greenamyre JT, Dunn C, Shoulson I.

Mov Disord. 1996 May;11(3):273-7.

PMID:
8723144
12.

Idebenone, a new drug in the treatment of cognitive impairment in patients with dementia of the Alzheimer type.

Bergamasco B, Scarzella L, La Commare P.

Funct Neurol. 1994 May-Jun;9(3):161-8.

PMID:
7988944
13.

A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease.

Weyer G, Babej-Dölle RM, Hadler D, Hofmann S, Herrmann WM.

Neuropsychobiology. 1997;36(2):73-82.

PMID:
9267856
14.

Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study.

Huntington Study Group TREND-HD Investigators.

Arch Neurol. 2008 Dec;65(12):1582-9. doi: 10.1001/archneur.65.12.1582. Erratum in: Arch Neurol. 2009 Mar;66(3):305.

PMID:
19064745
15.

Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.

Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, Müller T, Kupsch A, Henningsen H, Oertel WH, Fuchs G, Kuhn W, Niklowitz P, Koch R, Herting B, Reichmann H; German Coenzyme Q(10) Study Group.

Arch Neurol. 2007 Jul;64(7):938-44. Epub 2007 May 14.

PMID:
17502459
16.

Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial.

Verbessem P, Lemiere J, Eijnde BO, Swinnen S, Vanhees L, Van Leemputte M, Hespel P, Dom R.

Neurology. 2003 Oct 14;61(7):925-30.

PMID:
14557561
17.

Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial.

Puri BK, Leavitt BR, Hayden MR, Ross CA, Rosenblatt A, Greenamyre JT, Hersch S, Vaddadi KS, Sword A, Horrobin DF, Manku M, Murck H.

Neurology. 2005 Jul 26;65(2):286-92.

PMID:
16043801
18.

A controlled trial of fluoxetine in nondepressed patients with Huntington's disease.

Como PG, Rubin AJ, O'Brien CF, Lawler K, Hickey C, Rubin AE, Henderson R, McDermott MP, McDermott M, Steinberg K, Shoulson I.

Mov Disord. 1997 May;12(3):397-401.

PMID:
9159735
19.

Lithium treatment of Huntington's chorea. A placebo-controlled clinical trial.

Vestergaard P, Baastrup PC, Petersson H.

Acta Psychiatr Scand. 1977 Sep;56(3):183-8.

PMID:
143188
20.

Dosage effects of riluzole in Huntington's disease: a multicenter placebo-controlled study.

Huntington Study Group.

Neurology. 2003 Dec 9;61(11):1551-6.

PMID:
14663041

Supplemental Content

Support Center